Formulations for ocular treatment

Details for Australian Patent Application No. 2006213673 (hide)

International Classifications

Event Publications

23 August 2007 PCT application entered the National Phase

PCT publication WO2006/086744 Priority application(s): WO2006/086744

6 January 2011 Assignment before Grant

MacuSight, Inc. The application has been assigned to Santen Pharmaceutical Co., Ltd. Assignments before Grant, Section 113

6 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.